Healthcare

For investors monitoring the latest PME ASX announcement, the deal continues a pattern of high-value, multi-year contract wins with major U.S. health systems and provides further validation for Pro Medicus’ CloudPACS strategy. While past contracts do not guarantee future results, the update highlights the …

For investors monitoring ALC ASX announcements, the deal is structured to be immediately earnings accretive on completion (anticipated end June 2026), reflecting the Kyra flow products’ attractive recurring revenue and margin profile. This article summarises the verified terms, strategic rationale and risks. Following the …

For investors monitoring EMD ASX announcements, the activation of the Victorian clinic is positioned as a delivery milestone underpinned by infrastructure, workforce and funded patient pathways. This article summarises the verified details and considerations for investors.

CSL Ltd (ASX:CSL) was once viewed as one of the Australian share market’s most dependableLong-term Growthstories. For years, the biotechnology giant commanded premium valuations as investors rewarded its global plasmaBusiness, defensiveEarningsprofile and consistent expansion strategy.

Life360 Inc (ASX:360) has experienced a significant shift in market sentiment over the past six months, with its share price declining approximately 48% despite continued expansion in its global user base and recurring operationalCash Flowgeneration. The stock recently traded around A$18.30 on the ASX, …

Pro Medicus Limited (ASX:PME), the Melbourne-based healthcare informatics company, announced on 18 May 2026 the execution of a 7-year, A$90 million contract with Beth Israel Lahey Health, one of the most significant hospital networks in the eastern United States. The agreement, entered through the …

Vitasora Health Ltd (ASX:VHL) shares surged 36.36% to AUD 0.015 during the morning session on 18 May 2026 after the company released a favourable operational update highlighting accelerating patient enrolments, platform deployment progress and anticipated cost savings linked to its proprietary vCare system. Despite …